Proximity-enabled bidirectional enzymatic repairing amplification for ultrasensitive fluorescence sensing of adenosine triphosphate.


Journal

Analytica chimica acta
ISSN: 1873-4324
Titre abrégé: Anal Chim Acta
Pays: Netherlands
ID NLM: 0370534

Informations de publication

Date de publication:
01 Apr 2020
Historique:
received: 31 10 2019
revised: 28 12 2019
accepted: 02 01 2020
entrez: 29 2 2020
pubmed: 29 2 2020
medline: 26 11 2020
Statut: ppublish

Résumé

A novel fluorescence sensing strategy for ultrasensitive and highly specific detection of adenosine triphosphate (ATP) has been developed by the combination of the proximity ligation assay with bidirectional enzymatic repairing amplification (BERA). The strategy relies on proximity binding-triggered the release of palindromic tail that initiates bidirectional cyclic enzymatic repairing amplification reaction with the aid of polymerase and two DNA repairing enzymes, uracil-DNA glycosylase (UDG) and endonuclease IV (Endo IV). A fluorescence-quenched hairpin probe with a palindromic tail at the 3' end is skillfully designed that functions as not only the recognition element, primer, and polymerization template for BERA but also the indicator for fluorescence signal output. On the basis of the amplification strategy, this biosensor displays excellent sensitivity and selectivity for ATP detection with an outstanding detection limit of 0.81 pM. Through simultaneously enhancing the target response signal value and reducing nonspecific background, this work deducted the background effect, and showed high sensitivity and reproducibility. Moreover, our biosensor also shows promising potential in real sample analysis. Therefore, the proximity-enabled BERA strategy indeed creates a simple and valuable fluorescence sensing platform for ATP identification and related disease diagnosis and biomedical research.

Identifiants

pubmed: 32106947
pii: S0003-2670(20)30008-8
doi: 10.1016/j.aca.2020.01.006
pii:
doi:

Substances chimiques

Fluorescent Dyes 0
Adenosine Triphosphate 8L70Q75FXE
Deoxyribonuclease IV (Phage T4-Induced) EC 3.1.21.2
Uracil-DNA Glycosidase EC 3.2.2.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-163

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Shasha Li (S)

College of Biological Sciences and Technology, University of Jinan, Jinan, 250022, PR China.

Su Liu (S)

School of Water Conservancy and Environment, University of Jinan, Jinan, 250022, PR China.

Jingfeng Wang (J)

College of Biological Sciences and Technology, University of Jinan, Jinan, 250022, PR China.

Yihan Zhao (Y)

College of Biological Sciences and Technology, University of Jinan, Jinan, 250022, PR China.

Rufeng Zhang (R)

School of Water Conservancy and Environment, University of Jinan, Jinan, 250022, PR China.

Xiaonan Qu (X)

School of Water Conservancy and Environment, University of Jinan, Jinan, 250022, PR China.

Yu Wang (Y)

College of Biological Sciences and Technology, University of Jinan, Jinan, 250022, PR China. Electronic address: bio_wangy@ujn.edu.cn.

Jiadong Huang (J)

College of Biological Sciences and Technology, University of Jinan, Jinan, 250022, PR China; Key Laboratory of Chemical Sensing & Analysis in Universities of Shandong, College of Chemistry and Chemical Engineering, University of Jinan, Jinan, 250022, PR China.

Jinghua Yu (J)

Key Laboratory of Chemical Sensing & Analysis in Universities of Shandong, College of Chemistry and Chemical Engineering, University of Jinan, Jinan, 250022, PR China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH